Aotec Pharmaceutical: Cumulative repurchase of shares reached 4.18%, totaling 184 million yuan.

Osterreich Bio announced that as of July 17, 2026, the company has repurchased a total of 3.3175 million shares through centralized bidding trading, accounting for 4.18% of the total share capital of 79.2809 million shares. This is an increase of 0.54% compared to the previously disclosed number. The highest transaction price was 68.29 yuan per share, and the lowest price was 41.88 yuan per share, with a total payment of 184 million yuan. The company started the repurchase on February 9, 2026, with an expected amount of 100 million to 200 million yuan, and the repurchased shares are used to reduce the registered capital.